Uncovering Somatic Mosaic Variants of -related Overgrowth Disorders - Three Cases with Different Clinical Presentations

Overview

Journal Front Genet

Date 2025 Jan 28

PMID 39872006

Authors

M Tooming

P Mertsina

T Kahre

R Teek

I Vainumae

S Lilles

M H Wojcik

P Ilves

K Ounap

Affiliations

Soon will be listed here.

Abstract

Introduction: related disorders (PRD, OMIM: *171834) are genetic disorders resulting from pathogenic somatic mosaic variants in the gene, which encodes a protein crucial for regulating cell growth and division. PRD typically manifest during the post-zygotic phase, leading to a broad spectrum of overgrowth and vascular malformations affecting various body regions.

Methods: Conventional diagnostic methods struggle to detect and confirm pathogenic PIK3CA gene variants due to the mosaic nature of these disorders and the limited accessibility of affected tissues. In this study, we conducted comprehensive genomic profiling on a cohort of individuals with PRD to address these diagnostic challenges.

Results: Our analysis revealed significant diagnostic challenges posed by somatic mosaicism in PRD. The comprehensive genomic profiling allowed for the meticulous evaluation of potentially pathogenic gene variants in affected individuals and their corresponding tissues.

Discussion: Our findings advocate for the adoption of comprehensive genomic profiling in clinical practice to improve the detection and management of PRD. This approach can enhance patient care by providing a more accurate diagnosis and better understanding of the genetic underpinnings of PRD.

References

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

Maguolo A, Antoniazzi F, Spano A, Fiorini E, Gaudino R, Mauro M . Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene. Ital J Pediatr. 2018; 44(1):110. PMC: 6146629. DOI: 10.1186/s13052-018-0568-8. View

Shen X, Gasteratos K, Spyropoulou G, Yin F, Rui Y . Congenital difference of the hand and foot: Pediatric macrodactyly. J Plast Reconstr Aesthet Surg. 2022; 75(11):4054-4062. DOI: 10.1016/j.bjps.2022.06.059. View

Zenner K, Cheng C, Jensen D, Timms A, Shivaram G, Bly R . Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations. JCI Insight. 2019; 4(21). PMC: 6948764. DOI: 10.1172/jci.insight.129884. View

Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

Mills J, Moyer A, Kipp B, Poplawski A, Messiaen L, Babovic-Vuksanovic D . Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders. Clin Genet. 2017; 93(1):187-190. DOI: 10.1111/cge.13099. View

de Kock L, Cuillerier A, Gillespie M, Couse M, Hartley T, Mears W . Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach. Am J Med Genet A. 2023; 194(3):e63466. DOI: 10.1002/ajmg.a.63466. View

Singh S, Bradford D, Li X, Mishra-Kalyani P, Shen Y, Wang L . FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum. Clin Cancer Res. 2023; 30(1):23-28. PMC: 10841299. DOI: 10.1158/1078-0432.CCR-23-1270. View

Jenkins M, Ranga-Prasad H, Parson M, Harris N, Rathinaswamy M, Burke J . Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus. Nat Commun. 2023; 14(1):181. PMC: 9837058. DOI: 10.1038/s41467-023-35789-6. View

10.

Mirzaa G, Timms A, Conti V, Boyle E, Girisha K, Martin B . -associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 2016; 1(9). PMC: 5019182. DOI: 10.1172/jci.insight.87623. View

11.

Gazzin A, Leoni C, Viscogliosi G, Borgini F, Perri L, Iacoviello M . Work-Up and Treatment Strategies for Individuals with -Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association. Genes (Basel). 2023; 14(12). PMC: 10742781. DOI: 10.3390/genes14122134. View

12.

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

13.

Canaud G, Hammill A, Adams D, Vikkula M, Keppler-Noreuil K . A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis. 2021; 16(1):306. PMC: 8268514. DOI: 10.1186/s13023-021-01929-8. View

14.

Nadjkovic K, Lonabaugh K . Alpelisib: A Novel Agent for PIK3CA-Related Overgrowth Spectrum. J Pediatr Pharmacol Ther. 2023; 28(7):590-594. PMC: 10681085. DOI: 10.5863/1551-6776-28.7.590. View

15.

Faivre L, Crepin J, Reda M, Nambot S, Carmignac V, Abadie C . Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations. Clin Genet. 2023; 104(5):554-563. DOI: 10.1111/cge.14410. View

16.

Arafeh R, Samuels Y . PIK3CA in cancer: The past 30 years. Semin Cancer Biol. 2019; 59:36-49. DOI: 10.1016/j.semcancer.2019.02.002. View

17.

Cingolani P, Patel V, Coon M, Nguyen T, Land S, Ruden D . Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift. Front Genet. 2012; 3:35. PMC: 3304048. DOI: 10.3389/fgene.2012.00035. View

18.

Keppler-Noreuil K, Sapp J, Lindhurst M, Parker V, Blumhorst C, Darling T . Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014; 164A(7):1713-33. PMC: 4320693. DOI: 10.1002/ajmg.a.36552. View

19.

Chang F, Liu L, Fang E, Zhang G, Chen T, Cao K . Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel. J Mol Diagn. 2017; 19(4):613-624. DOI: 10.1016/j.jmoldx.2017.04.006. View

20.

Garel C, Cont I, Alberti C, Josserand E, Moutard M, Ducou Le Pointe H . Biometry of the corpus callosum in children: MR imaging reference data. AJNR Am J Neuroradiol. 2011; 32(8):1436-43. PMC: 7964359. DOI: 10.3174/ajnr.A2542. View